Evaluating Sublingual immunotherapy in allergic Rhinoconjunctivitis

计划入组 120 人

Probiotic Chewables in Allergic Rhinoconjunctivitis Patients

计划入组 64 人 · 首次发布于 2021 年 5 月 24 日

Study of BLU-808 in Allergic Rhinoconjunctivitis

计划入组 21 人 · 首次发布于 2025 年 4 月 10 日

dust mite allergen immunotherapy (sublingual spray, allergic rhinitis/rhinoconjunctivitis)

Mizolastine

C₂₄H₂₅FN₆O · Rx

Diagnostic Patch for Allergic Contact Dermatitis

Rx

Third Harmonic Bio

United States

Gossamer Bio

United States

Xencor

United States

Allergic Rhinoconjunctivitis Market Set for Evolution Through 2036 as Immunotherapy Access Expands

Stallergenes Greer's Staloral Birch Achieves Primary Endpoint in Pediatric Phase III Trial for Allergic Rhinoconjunctivitis

ALK's House Dust Mite SLIT-Tablet Phase 3 Trial Results Published in The Lancet Regional Health – Europe